MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Evaluation of motor impulsivity in Huntington Disease with a choice reaction time task and brain metabolic (PET 18FDG) imaging

    S. Grimaldi, E. Guedj, F. Fluchere, T. Hasbroucq, F. Vidal, JP. Azulay (Marseille, France)

    Objective: To describe motor impulsivity in early Huntington disease (HD) with electromyographic (EMG) recordings during a choice reaction time task (Simon Task) and brain metabolic…
  • 2018 International Congress

    Assessing the potential of EEG as a biomarker in Huntington’s disease using machine learning automatic classification

    O. Odish, K. Johnsen, P. van Someren, R. Roos, G. van Dijk (Leiden, Netherlands)

    Objective: To construct an automatic classifier distinguishing healthy controls from Huntington’s disease (HD) gene carriers using quantitative electroencephalography (qEEG) and to derive qEEG features that…
  • 2018 International Congress

    Exploration of insight competence in Huntington’s disease supplemental to a cognitive debriefing study for the FuRST2.0 rating scale

    R. Fuller, P. Feigenbaum, C. Fitzer-Attas, N. La Pelle, S. Luo, C. Sampaio, G. Stebbins (Princeton, NJ, USA)

    Objective: Evaluate insight of functional impairment in premanifest and early-manifest Huntington’s disease (HD). Background: Following the guidelines of the US Food and Drug Administration Clinical…
  • 2018 International Congress

    Late onset Huntington’s disease in an Argentinian cohort

    M. Cesarini, J. Etcheverry, E. Gatto, J. Ziliani, G. Da Prat, N. Gonzalez Rojas, V. Parisi, G. Persi (Buenos Aires, Argentina)

    Objective: To describe the prevalence, clinical and molecular characteristics of a series of LOHD patients in an Argentinean cohort. Background: Late onset Huntington’s disease (LOHD)…
  • 2018 International Congress

    On the hunt for a link between genetically confirmed Huntington’s disease and Amyotrophic Lateral Sclerosis

    L. Williams, K. O'Connell, D. Burke, J. Cryan, D. McCabe (Dublin, Ireland)

    Objective: To characterise the clinical and pathologic findings of Huntington’s disease (HD) and coincident amyotrophic lateral sclerosis (ALS). Background: A 66 year old man presented…
  • 2018 International Congress

    The distinct cognitive syndromes of Huntington’s disease: A two-year follow-up study

    S. Martinez-Horta, F. Sampedro, A. Horta-Barba, J. Perez-Perez, J. Pagonabarraga, J. Marin-Lahoz, H. Bejr-Kasem, I. Aracil, MA. Boti, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore if patients can be clustered into different groups based on dissimilar patterns of cognitive deterioration in a 2-year follow-up; to study the…
  • 2018 International Congress

    Cerebrospinal fluid flow dynamics in Huntington’s disease evaluated by phase contrast MRI

    F. Rodrigues, L. Byrne, E. De Vita, E. Johnson, N. Hobbs, J. Thornton, R. Scahill, E. Wild (London, United Kingdom)

    Objective: To elucidate the dynamics of CSF flow through the neuraxis in Huntington’s disease (HD) using phase contrast magnetic resonance imaging (PCMRI). Background: HD is…
  • 2018 International Congress

    Submandibular gland is a suitable tissue for alpha synuclein pathology in Parkinson’s disease

    JH. Shin, SH. Park, CW. Shin, JH. Kim, TJ. Yun, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To validate the role of α-synuclein (AS) pathology in submandibular gland (SMG) as a biomarker for Parkinson disease (PD). Background: The pathologic hallmark of…
  • 2018 International Congress

    2 cases of Parkinonism secondary to neurosyphilis

    M. Li, F. Lou, Y. Ren, X. Luo (Shenyang, China)

    Objective: To report two cases of Parkinsonism secondary to neurosyphilis. Background: Neurosyphilis can cause various neurological manifestations, but rarely Parkinsonism. Methods: We collect information, clinical…
  • 2018 International Congress

    An extraordinary cause of psychosis: Anti-NMDA receptor encephalitis

    H. Batur Caglayan, F. Sahin, T. Altıparmak, E. Turksoy, S. Candansayar, A. Bora Tokcaer (Ankara, Turkey)

    Objective: Anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis is an autoimmune encephalitis affecting predominantly young females. Background: It is characterized with neuropsychiatric symptoms, including personality changes, psychosis, autonomic…
  • « Previous Page
  • 1
  • …
  • 1275
  • 1276
  • 1277
  • 1278
  • 1279
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley